This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ito, H. Articles by Minamino, T. Search for Related Content PubMed PubMed Citation Articles by Ito, H. Articles by Minamino, T.

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

Hiroshi Ito, MD^*, Yoshiaki Taniyama, MD^*, Katsuomi Iwakura, MD^*, Nagahiro Nishikawa, MD^*, Tohru Masuyama, MD, Tsunehiko Kuzuya, Masatsugu Hori, MD, Yorihiko Higashino, MD^*, Kenshi Fujii, MD^* and Takazo Minamino, MD^*

^* Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan
First Department of Medicine, Osaka University School of Medicine, Osaka, Japan

View larger version (31K): [in a new window]   Figure 1 Comparison of frequency of MCE no reflow between nicorandil and control groups. Frequency of MCE no reflow was significantly lower in the nicorandil group than in the control group. Relative risk for MCE no reflow with nicorandil was 0.34. Abbreviations: CI = confidence interval; MCE = myocardial contrast echocardiography.